Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Braz. arch. biol. technol ; 64: e21200402, 2021. tab, graf
Article in English | LILACS | ID: biblio-1249214

ABSTRACT

Abstract Clostridium difficile infection (CDI) is the most common hospital acquired diarrheal disease with its increasing incidence and mortality rate globally. DNA Gyrase B (GyrB) is a key component of DNA replication process across all bacterial genera; thus, this offers a potential target for the treatment of CDI. In the present study, several virtual screening approaches were employed to identify a novel C. difficile GyrB inhibitor. The 139 known metabolites were screened out from the 480 flavonoids in PhytoHub database. Molinspiration and PROTOX II servers were used to calculate the ADME properties and oral toxicity of the metabolites, whereas mutagenicity, tumorigenicity, irritant, and reproductive effect were predicted using DataWarrior program. The binding mode and the binding efficiency of the screened flavonoids against the GyrB were studied using FlexX docking program. From virtual screening of 139 metabolites, we found 25 flavonoids with no mutagenicity, tumorigenicity, irritant, and reproductive effect. Docking study suggested that flavonoids 1030 ((-)-epicatechin 3'-O-sulfate), 1032 ((-)-epicatechin 4'-O-sulfate), 1049 (3'-O-methyl-(-)-epicatechin 4-O-sulfate), 1051 (3'-O-methyl-(-)-epicatechin 7-O-sulfate), 1055 (4'-O-methyl-(-)-epicatechin 7-O-sulfate) and 1317 (quercetin sulfate) have significantly higher binding affinity than the known GyrB inhibitor novobiocin. The results from molecular dynamics simulation and free energy calculations based on solvated interaction energy suggested that (-)-epicatechin 3'-O-sulfate could be a potential drug candidate in the management of CDI.


Subject(s)
Flavonoids/therapeutic use , Clostridium Infections/therapy , DNA Gyrase/therapeutic use , High-Throughput Screening Assays
2.
Article in English | IMSEAR | ID: sea-154698

ABSTRACT

Restoration of a traumatically injured tooth presents a clinical challenge for a predictable aesthetic outcome. This case report describes a multidisciplinary approach of a subgingivally fractured permanent maxillary central incisor. A removable orthodontic appliance was used for orthodontic extrusion of root, and surgical gingival recontouring was done with electrocautery to reestablish the biological width. Form and function were restored establishing biological width and esthetics was repaired with porcelain fused to metal crown.


Subject(s)
Adolescent , Gingiva/surgery , Humans , Incisor/injuries , Incisor/surgery , Male , Orthodontic Appliances, Removable/therapeutic use , Orthodontic Appliances, Removable/statistics & numerical data , Orthodontic Extrusion/therapeutic use , Orthodontic Extrusion/statistics & numerical data , Tooth Crown/injuries , Tooth Crown/surgery , Tooth Fractures/surgery , Tooth Root/therapy
3.
Article in English | IMSEAR | ID: sea-154602

ABSTRACT

Talon cusp is a relatively rare developmental dental anomaly thought to arise as a result of evagination on the surface of a tooth crown before calcification has occurred. It is characterized by cusp‑like projections from the cingulum area, or cemento‑enamel junction of maxillary or mandibular anterior teeth, in both the primary and permanent dentition, usually observed on the lingual surface of the affected tooth. The cusp may or may not contain an extension of the pulp. The etiology remains unknown. The incidence is 0.04‑8%. Any tooth may have a talon cusp but most of the cases involve maxillary lateral incisors. The anomaly has been reported to be rare especially when it occurs on mandibular teeth. This article reports a case of talon cusp on permanent mandibular central incisor that too on facial aspect which makes it a rare entity.


Subject(s)
Adult , Fused Teeth , Humans , Incisor/abnormalities , Humans , Tooth Crown/abnormalities
4.
Article in English | IMSEAR | ID: sea-154560

ABSTRACT

Pleomorphic adenoma (PA) is the most common tumor of the salivary glands. About 90% of these tumors occur in the parotid gland and 10% in the minor salivary glands. The most common sites of PA of the minor salivary glands are the palate, followed by lips and cheeks. Throat, floor of the mouth, tongue, tonsil, pharynx, retromolar area and nasal cavity are rarely involved. Here, we report a case of PA of the cheek in a 42-year-old female. The mass was excised and the patient was followed for 3 years post operatively with no recurrence.


Subject(s)
Adenoma, Pleomorphic/diagnosis , Adult , Cheek , Epithelial Cells/cytology , Female , Humans , Review Literature as Topic , Salivary Glands, Minor
SELECTION OF CITATIONS
SEARCH DETAIL